Pfizer Inc
SGO:PFE
Pfizer Inc
SGO:PFE
Price:
49.19
USD
-0.36%
Market Closed
Market Cap:
$165.2B
Relative Value
The Relative Value of one
PFE
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 49.19 USD,
Pfizer Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PFE Relative Value
HIDDEN
Multiples Across Competitors
PFE Competitors Multiples
Pfizer Inc Competitors
Pfizer Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pfizer Inc
SGO:PFE
|
153.9B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
992.9B USD | 15.2 | 48.1 | 32.4 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
283.1B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.6B CHF | 5.3 | 21.3 | 13.2 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.3B GBP | 5.2 | 31.9 | 15.2 | 22.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.1B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.6 | 10 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.2B USD | 2.6 | 17.5 | 6.8 | 8.8 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.1B GBP | 2.7 | 15.5 | 7.8 | 11.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
